[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pacific Biosciences of California Inc (PACB) - Financial and Strategic SWOT Analysis Review

August 2021 | 50 pages | ID: PD349F74BF2EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Pacific Biosciences of California Inc (PACB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Pacific Biosciences of California Inc (Pacific Biosciences) designs, develops, and manufactures sequencing instruments for solving complex genetic abnormalities. The company’s product portfolio comprises proprietary Phospholinked nucleotides, sequencing systems, analytical software and consumables. Its products enable the identification of novel genes; characterization of alternatively spliced isoforms in prominent gene families, and targeted sequencing, and provide real-time kinetic data for characterization of epigenomes. Pacific Biosciences' products are based on its novel single molecule, real-time (SMRT) sequencing technology. It caters to scientific and research communities, government and commercial entities. The company has subsidiaries in the US, Canada, Japan, Germany, China, Singapore, and the UK. Pacific Biosciences is headquartered in Menlo Park, California, the US.

Pacific Biosciences of California Inc Key Recent Developments

Aug 09,2021: Pacific Biosciences of California to Present at Upcoming Investor Conference
Aug 03,2021: Pacific Biosciences of California, Inc. Announces Second Quarter 2021 Financial Results
Jul 20,2021: Pacific Biosciences and Invitae announce intent to expand collaboration
Jul 19,2021: Pacific Biosciences of California Second Quarter 2021 Financial Results Call
Jul 19,2021: Pacific Biosciences of California, Inc. Second Quarter 2021 Financial Results Call

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Pacific Biosciences of California Inc - Key Facts
Pacific Biosciences of California Inc - Key Employees
Pacific Biosciences of California Inc - Key Employee Biographies
Pacific Biosciences of California Inc - Major Products and Services
Pacific Biosciences of California Inc - History
Pacific Biosciences of California Inc - Company Statement
Pacific Biosciences of California Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Pacific Biosciences of California Inc - Business Description
Business Segment: Product Revenue
Performance
Business Segment: Service and Other
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe (including the Middle East and Africa)
Performance
Geographical Segment: North America
Performance
R&D Overview
Pacific Biosciences of California Inc - Corporate Strategy
Pacific Biosciences of California Inc - SWOT Analysis
SWOT Analysis - Overview
Pacific Biosciences of California Inc - Strengths
Pacific Biosciences of California Inc - Weaknesses
Pacific Biosciences of California Inc - Opportunities
Pacific Biosciences of California Inc - Threats
Pacific Biosciences of California Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Pacific Biosciences of California Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Pacific Biosciences of California Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Pacific Biosciences of California Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 09, 2021: Pacific Biosciences of California to Present at Upcoming Investor Conference
Aug 03, 2021: Pacific Biosciences of California, Inc. Announces Second Quarter 2021 Financial Results
Jul 20, 2021: Pacific Biosciences and Invitae announce intent to expand collaboration
Jul 19, 2021: Pacific Biosciences of California Second Quarter 2021 Financial Results Call
Jul 19, 2021: Pacific Biosciences of California, Inc. Second Quarter 2021 Financial Results Call
Jun 23, 2021: Pacific Biosciences and Rady Children’s Institute for Genomic Medicine announce its first research collaboration for whole genome sequencing
Jun 08, 2021: Pacific Biosciences Welcomes Neil Ward to Its Leadership Team as Vice President and General Manager for Europe, Middle East, and Africa
May 17, 2021: Pacific Biosciences Further Expands Leadership Team with Appointment of Dr. Catherine Ball to Newly Created Position of Senior Vice President of Research
May 14, 2021: Pacific Biosciences of California: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Apr 29, 2021: Pacific Biosciences of California Announces First Quarter 2021 Financial Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Pacific Biosciences of California Inc, Key Facts
Pacific Biosciences of California Inc, Key Employees
Pacific Biosciences of California Inc, Key Employee Biographies
Pacific Biosciences of California Inc, Major Products and Services
Pacific Biosciences of California Inc, History
Pacific Biosciences of California Inc, Subsidiaries
Pacific Biosciences of California Inc, Key Competitors
Pacific Biosciences of California Inc, Ratios based on current share price
Pacific Biosciences of California Inc, Annual Ratios
Pacific Biosciences of California Inc, Annual Ratios (Cont...1)
Pacific Biosciences of California Inc, Interim Ratios
Pacific Biosciences of California Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Pacific Biosciences of California Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Pacific Biosciences of California Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Pacific Biosciences of California Inc, Performance Chart (2016 - 2020)
Pacific Biosciences of California Inc, Ratio Charts
Pacific Biosciences of California Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Pacific Biosciences of California Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021


More Publications